--- title: "为什么 Virax Biolabs (VRAX) 的股票在夜间成为热门话题？" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/286858214.md" description: "Virax Biolabs (VRAX) 的股票在盘后交易中上涨了 17.36%，达到 0.28 美元，此前在日内交易中上涨了 53.09%。Armistice Capital 披露其在 VRAX 中持有 4.99% 的股份。该公司正在推进 ViraxImmune，旨在针对急性感染后综合症。尽管市值为 479 万美元，但 VRAX 的股票在过去一年中下跌了 78.04%，交易价格接近其 52 周低点 0.10 美元" datetime: "2026-05-19T05:09:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286858214.md) - [en](https://longbridge.com/en/news/286858214.md) - [zh-HK](https://longbridge.com/zh-HK/news/286858214.md) --- # 为什么 Virax Biolabs (VRAX) 的股票在夜间成为热门话题？ **Virax Biolabs Group Limited ( VRAX )** shares are trending on Tuesday. VRAX shares rose 17.36% to $0.28 in after-hours trading on Monday. The jump in the late trading session follows an intraday gain of 53.09%, closing the stock at $0.24, according to Benzinga Pro data. ## Armistice Capital Takes 4.99% Stake in VRAX On May 15, **Armistice Capital**, LLC, a New York-based hedge fund, filed a **Securities and Exchange Commission** disclosure revealing a 4.99% beneficial ownership stake of over 1 million ordinary shares. The fund was founded in 2012 by Managing Member **Steven Boyd**, who signed the filing. Last month, Virax Biolabs ( VRAX ) announced it is advancing **ViraxImmune**, a proprietary assay targeting post-acute infection syndromes including Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a space the company estimates carries a U.S. economic burden exceeding $25 billion. ## Trading Metrics, Technical Analysis Virax, an innovative biotechnology company, has a market capitalization of $4.79 million. Its stock has traded between a 52-week high of $1.18 and a 52-week low of $0.10. VRAX's Relative Strength Index (RSI) is 69.52. Over the past 12 months, the stock of the biotech has dropped 78.04%. Currently, VRAX is positioned at about 13% of the way up from its 52-week low to its high, meaning the stock is trading closer to its annual low. **Benzinga’s Edge Stock Rankings** indicate that VRAX has a negative price trend across all time frames.
_Photo Courtesy: Gorodenkoff on Shutterstock.com_ **Disclaimer:** This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. **Read Also: Bakkt (BKKT) Stock Jumps Over 16% After Hours: Here's Why The ICE-Backed Crypto Platform Is Trending Overnight** ### 相关股票 - [VRAX.US](https://longbridge.com/zh-CN/quote/VRAX.US.md) - [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md) - [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md) - [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md) - [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md) - [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md) - [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md) - [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md) - [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md) - [BKKT.US](https://longbridge.com/zh-CN/quote/BKKT.US.md) - [BKKT+.US](https://longbridge.com/zh-CN/quote/BKKT+.US.md) ## 相关资讯与研究 - [“搞钱”，才是 Revolution 千亿神话密码](https://longbridge.com/zh-CN/news/286888792.md) - [XORTX 获战略投资](https://longbridge.com/zh-CN/news/286767527.md) - [BioMarin ENPP1 缺乏症三期临床试验折戟，BMN 401 未达临床获益终点](https://longbridge.com/zh-CN/news/286795745.md) - [定义 “医院 AI 操作系统”：北协和、南湘雅等顶级医院 为何集体选择医渡科技？](https://longbridge.com/zh-CN/news/286870257.md) - [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md)